Owkin
Breakthrough medical moments powered by A.I. transforming data into knowledge through collaboration and machine learning technologies to discover the medicine of tomorrow.
PARIS, FRANCE
More about Owkin
NJF Capital presents OWKIN. Researchers, doctors and biologists benefit from the massive amount of available information as health data becomes digitised. However, it also becomes harder for humans to uncover the complexity and extract insights. Data is generated at a much faster pace than knowledge. This is the scientific challenge. There is also a social challenge in the healthcare industry - privacy of individual data.
Owkin transforms data into knowledge. Owkin builds mathematical models and algorithms that can interpret biomedical images, genomics and clinical data to discover biomarkers and mechanisms associated with diseases and treatment outcomes. Owkin’s platform, Socrates, constantly learns from heterogeneous data to create unique prediction models for automated diagnostics, prediction of drug response, survival prognostics and clinical trial optimisation. Owkin has solved the social challenge of privacy of individual data by building collective intelligence from distributed data at scale. The overall outcome is the provision of personalised treatments – faster, cheaper and of better quality – for everyone.
Owkin in the news
NJF Capital Blog
